Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

Detalles Bibliográficos
Autores principales: Khalafallah, Alhossain, Brain, Terry
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033134/
https://www.ncbi.nlm.nih.gov/pubmed/21415965
http://dx.doi.org/10.4084/MJHID.2010.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033134/
https://www.ncbi.nlm.nih.gov/pubmed/21415965
http://dx.doi.org/10.4084/MJHID.2010.012

Ejemplares similares